Chelsea and Westminster Hospital NHS Foundation Trust, Therapies Department, London United Kingdom.
Imperial College London, Faculty of Medicine, Department of Medicine, London, United Kingdom.
PLoS One. 2019 Jul 10;14(7):e0213222. doi: 10.1371/journal.pone.0213222. eCollection 2019.
To evaluate the psychometric properties of the HIV Disability Questionnaire (HDQ) among people living with HIV (PLHIV) in London, United Kingdom (UK).
This is a cross-sectional measurement study. We recruited and administered the self-reported HDQ, seven criterion measures, and a demographic questionnaire with adults living with HIV accessing HIV care. We determined median and interquartile ranges (IQR) for disability presence, severity and episodic scores (range 0-100). We calculated Cronbach's alpha (α) Kuder-Richardson-20 (KR-20) statistics for disability and episodic scores respectively (internal consistency reliability), smallest detectable change (SDC) for each HDQ severity item and domain (precision), and tested 36 a priori hypotheses assessing correlations between HDQ and criterion scores (construct validity).
Of N = 243 participants, all were male, median age 40 years, 94% currently taking antiretroviral therapy, and 22% living with ≥2 concurrent health conditions. Median HDQ domain scores ranged from 0 (IQR: 0,7) (difficulties with day-to-day activities domain) to 27 (IQR: 14, 41) (uncertainty domain). Cronbach's alpha for the HDQ severity scale ranged from 0.85 (95% Confidence Interval (CI): 0.80-0.90) in the cognitive domain to 0.93 (95%CI: 0.91-0.94) in the mental-emotional domain. The KR-20 statistic for the HDQ episodic scale ranged from 0.74 (95%CI: 0.66-0.83) in the cognitive domain to 0.91 (95%CI: 0.89-0.94) in the uncertainty domain. SDC ranged from 7.3-15.0 points on the HDQ severity scale for difficulties with day-to-day activities and cognitive symptoms domains, respectively. The majority of the construct validity hypotheses (n = 30/36, 83%) were confirmed.
The HDQ possesses internal consistency reliability and construct validity with varied precision when administered to males living with HIV in London, UK. Clinicians and researchers may use the HDQ to measure the nature and extent of disability experienced by PLHIV in the UK, and to inform HIV service provision to address the health-related challenges among PLHIV.
评估 HIV 残疾问卷(HDQ)在英国伦敦 HIV 感染者(PLHIV)中的心理测量特性。
这是一项横断面测量研究。我们招募并管理了自我报告的 HDQ、七个标准测量和一份包含接受 HIV 护理的成年 HIV 感染者的人口统计问卷。我们确定了残疾存在、严重程度和发作评分的中位数和四分位间距(IQR)(范围 0-100)。我们分别计算了残疾和发作评分的克朗巴赫 α(α)Kuder-Richardson-20(KR-20)统计量(内部一致性可靠性)、每个 HDQ 严重程度项目和域的最小可检测变化(SDC)(精度),并测试了 36 个假设性假设,评估了 HDQ 与标准评分之间的相关性(结构有效性)。
在 N = 243 名参与者中,所有人均为男性,中位年龄 40 岁,94%目前正在接受抗逆转录病毒治疗,22%同时患有≥2 种健康状况。HDQ 域评分的中位数范围从 0(IQR:0,7)(日常生活活动域)到 27(IQR:14,41)(不确定性域)。HDQ 严重程度量表的克朗巴赫 α 范围从认知域的 0.85(95%置信区间(CI):0.80-0.90)到精神情绪域的 0.93(95%CI:0.91-0.94)。HDQ 发作量表的 KR-20 统计量范围从认知域的 0.74(95%CI:0.66-0.83)到不确定性域的 0.91(95%CI:0.89-0.94)。HDQ 严重程度量表中,日常活动和认知症状域分别为 7.3-15.0 分。大多数结构有效性假设(n = 30/36,83%)得到了证实。
当在英国伦敦的 HIV 感染者中使用时,HDQ 具有内部一致性可靠性和结构有效性,具有不同的精度。临床医生和研究人员可以使用 HDQ 来衡量英国 PLHIV 经历的残疾的性质和程度,并为 HIV 服务的提供提供信息,以解决 PLHIV 的健康相关挑战。